Saturday, November 26, 2022
Home Tags Sema4

Tag: Sema4

Sema4 cuts 500 jobs, closes Stamford laboratory

The biotech company Sema4 (NASDAQ:SMFR) has announced it is laying off 500 employees and closing the 70,000-square-foot laboratory in Stamford that it opened less...

Sema4 taps Kevin Feeley as CFO

This is the first executive appointment since the company laid off 250 workers earlier this month.

Sema4’s president and 250 employees out of work following dismal Q2...

Sema4's hereditary cancer testing operations were being moved from Stamford to Maryland.

New CEO at Sema4

Stueland was formerly president and CEO of GeneDX.

Sema4 co-authors study on new lung cancer therapy

Early diagnosis of lung adenocarcinoma is critical to improving the chances for survival.

Sema4 acquires GeneDx in pivot back to core mission

The transaction came with a $200 million infusion of capital from private placement investors.

BLT setting the pace in Stamford real estate development – and...

“Very few of those who moved here from New York City have moved back at the end of their lease terms, and most have chosen to stay,” boasted BLT Co-president Michael Handler.

Sema4 names IBM Research veteran as first chief science officer

Gustavo Stolovitzky spent 23 years at IBM Research, where he was appointed IBM Fellow, the highest technical honor bestowed by IBM.

Stamford’s Sema4 going public

The new entity will begin trading its shares of common stock and warrants on the Nasdaq Global Select Market under the ticker symbols "SMFR" and “SMFRW.”

Stamford’s Sema4 partners with AdventHealth to optimize patient care and outcomes

The companies initially will focus on accelerating research in AdventHealth’s Orlando-area network.

Wall Street and health care intersect for pair of Fairfield County...

Sema4 and Signify Health are raking in big bucks: The former through a merger with an eye toward going public, and the latter via its own IPO.

Stamford’s Sema4 being acquired in deal valued at $2B; Will go...

“The additional resources will allow us to greatly accelerate our business plans organically and inorganically, developing and bringing in more cutting-edge precision model solutions across multiple disease areas,” said Sema4 Founder and CEO Eric Schadt.

NYC exodus: CBRE exec says Fairfield County has two years to...

“New York City is out of lab space, or it’s too expensive,” says Stamford Director of Economic Development Thomas Madden, “so those companies can migrate into Westchester County or Stamford.”

Oncologist William K. Oh named chief medical science officer at Sema4

Oh has authored more than 300 articles, reviews, and book chapters related to cancers.

Sema4 opens 70,000-square-foot clinical lab in Stamford

Genomics-testing company Sema4 this morning opened its second clinical laboratory in Connecticut. The newly built 70,000-square-foot facility in Stamford – first announced in July 2019 –...